Substitute 1-(piperidin-4-yl)-3-(aryl)-isothioureas, their preparation and therapeutic use
申请人:Pierre Fabre Medicament
公开号:US06583159B1
公开(公告)日:2003-06-24
The invention concerns compounds of formula (I) wherein: R1 and R2, identical or different, represent a saturated or unsaturated alkyl radical, branched or not and containing 1 to 7 carbon atoms; R3 to R8, identical or different, represent a hydrogen, an alkyl branched or not and containing 1 to 5 carbon atoms, an acyloxy, branched or not and containing 1 to 5 carbon atoms, a halogeno, nitro, hydroxy, acyl or alkoxy group containing 1 to 5 carbon atoms, a dialkylamino group containing 1 to 5 carbon atoms, a trifluoromethyl or trifluoro methoxyl group; Z represents an oxygen or sulphur atom or methylene; m represents an integer between 0 and 4 inclusively; n represents an integer between 2 and 7 inclusively; and their pure enantiomers and mixtures, the therapeutically acceptable mineral or organic salts of the compounds of formula (I) and their possible hydrates.
本发明涉及式(I)的化合物,其中:R1和R2,相同或不同,代表饱和或不饱和的烷基基团,分支或不分支,含有1到7个碳原子;R3至R8,相同或不同,代表氢,分支或不分支的烷基,含有1到5个碳原子的酰氧基团,分支或不分支,含有1到5个碳原子的卤素,硝基,羟基,酰基或烷氧基团,含有1到5个碳原子的双烷基氨基团,三氟甲基或三氟甲氧基团;Z代表氧或硫原子或亚甲基;m代表0到4之间的整数;n代表2到7之间的整数;以及它们的纯对映体和混合物,化合物的治疗上可接受的矿物质或有机盐及其可能的水合物。